Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.95 is 43% below its 5-year average of 3.43, near the high end of its 5-year range (-46.59–5.93).
As of the fiscal period ended Tuesday, June 30, 2026. 123.57% above its 12-month average of -8.26.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.95.
QUICK RATIO (ACID-TEST)
1.95
QUICK RATIO (ACID-TEST) AVG TTM
-8.26
QUICK RATIO (ACID-TEST) AVG 3Y
-2.55
QUICK RATIO (ACID-TEST) AVG 5Y
3.43
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+123.57%
CURRENT VS 3Y AVG
+176.32%
CURRENT VS 5Y AVG
-43.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.80
median of 453 covered companies
CURRENT VS SECTOR MEDIAN
-30.50%
vs the sector median at left
20/20 Biolabs Inc.
Market Cap
$4.32M
Quick Ratio (Acid-Test)
1.95
TTM Avg
-8.26
3Y Avg
-2.55
5Y Avg
3.43
Market Cap
$4.41M
Quick Ratio (Acid-Test)
2.01
TTM Avg
0.91
3Y Avg
1.26
5Y Avg
1.78
Market Cap
$4.42M
Quick Ratio (Acid-Test)
1.35
TTM Avg
3.30
3Y Avg
6.18
5Y Avg
6.77
Market Cap
$4.46M
Quick Ratio (Acid-Test)
2.73
TTM Avg
3.29
3Y Avg
4.75
5Y Avg
4.47
Market Cap
$3.94M
Quick Ratio (Acid-Test)
2.08
TTM Avg
2.77
3Y Avg
2.83
5Y Avg
2.68
Market Cap
$4.79M
Quick Ratio (Acid-Test)
7.22
TTM Avg
2.13
3Y Avg
2.10
5Y Avg
5.04
Market Cap
$4.85M
Quick Ratio (Acid-Test)
5.58
TTM Avg
4.46
3Y Avg
3.04
5Y Avg
7.15
Market Cap
$4.96M
Quick Ratio (Acid-Test)
1.84
TTM Avg
1.72
3Y Avg
1.97
5Y Avg
1.97
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 20/20 Biolabs Inc. (AIDX) | $4.32M | 1.95 | -8.26 | -2.55 | 3.43 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | 2.01 | 0.91 | 1.26 | 1.78 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | 1.35 | 3.30 | 6.18 | 6.77 |
| GRI Bio, Inc. (GRI)vs › | $4.18M | 10.30 | 3.34 | 1.98 | 1.38 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | 2.73 | 3.29 | 4.75 | 4.47 |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.94M | 2.08 | 2.77 | 2.83 | 2.68 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | 7.22 | 2.13 | 2.10 | 5.04 |
| CalciMedica, Inc. (CALC)vs › | $4.85M | 5.58 | 4.46 | 3.04 | 7.15 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $4.96M | 1.84 | 1.72 | 1.97 | 1.97 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | 0.09 | 0.18 | 0.40 | 0.95 |
Quick Ratio
1.95
Excludes inventory
Current Ratio
1.99
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.95 |
| 2026-03-31 | 1.78 |
| 2025-12-31 | -46.59 |
| 2025-09-30 | 0.76 |
| 2025-06-30 | 0.82 |
| 2024-12-31 | 1.47 |
| 2024-09-30 | 0.00 |
| 2023-12-31 | 4.19 |
| 2023-09-30 | 4.19 |
| 2023-06-30 | 5.93 |
| 2023-03-31 | 5.82 |
| 2022-12-31 | 5.92 |
| 2022-09-30 | 5.92 |
| 2022-06-30 | 5.92 |
| 2021-12-31 | 3.41 |
| 2021-09-30 | 3.41 |
